openPR Logo
Press release

Global Human Papillomavirus (HPV) Therapeutics Market to Reach US$2.34 bn by 2020, Driven by Rising Prevalence of HPV Infections

08-09-2016 08:19 AM CET | Health & Medicine

Press release from: TMR Market Research

The global market for HPV and CMV therapeutics features numerous healthcare industry giants such as Roche AG, Valeant Pharmaceuticals, AbbVie Inc., Fresenius Kabi USA, Perrigo Company plc, Actavis plc, Fougera Pharmaceuticals, and Merck & Co. According to Transparency Market Research, Valeant Pharmaceuticals, Fougera Pharmaceuticals, and Perrigo Company plc held a dominant 89.2% share in the global HPV therapeutics market in 2013, while the leaders in the CMV therapeutics market were Roche AG, Clinigen Group plc, and Fresenius Kabi USA, who collectively accounted for 93% of the market.

Download Free Sample Research Report: http://bit.ly/2aNNCAj

The key opportunity for manufacturers of HPV and CMV therapeutics is the development of biologics and drugs with a low risk of possible toxicity. HPV therapeutics, in particular, have benefited immensely from the growing awareness about the adverse effects of the HPV vaccine. On the other hand, the CMV therapeutics is set to witness a growing demand for CMV vaccines, leading to players operating in both markets having to establish research into both product lines. This could result in increased consolidation of the HPV and CMV therapeutics market in the coming years, as smaller players may not be able to afford developing both product lines.

Expanding Healthcare Sector in Emerging Economies to Drive Demand for HPV, CMV Therapeutics

The prime driver for the global HPV and CMV therapeutics market is the increasing prevalence of both diseases in emerging regions such as Asia Pacific and Latin America. The ongoing cultural shift in these regions has contributed to an increase in the prevalence of sexually transmitted diseases and is thus a driver for the HPV therapeutics market. Thanks to the rapid ongoing development of the healthcare sector, developing regions present lucrative opportunities for manufacturers of both HPV and CMV therapeutics. This has led to many leading market players focusing on maximizing their performance in underdeveloped/developing economies.

The increasing demand for replacements for HPV vaccines is another key driver for the global HPV therapeutics market. Digestive distress, fever, headaches, and skin irritations at the site of the injection are some of the side effects of the HPV vaccine. The growing awareness regarding the risk of the same has resulted in growing public demand for HPV therapeutics instead.

Lack of Awareness in Key Markets Hurting HPV, CMV Therapeutics Market

On the other hand, despite the advancements in the healthcare sector, the lack of awareness about the etiology and treatment of HPV and CMV is hampering the market in emerging regions, as the rate of diagnosis among patients is quite low. This is a key restraint for the HPV and CMV therapeutics market in the coming years and is likely to be ameliorated by sustained efforts from healthcare bodies as well as manufacturers of HPV and CMV therapeutics.

Genital Warts to Remain Leading Application of HPV Therapeutics

Of the various ways in which HPV manifests, genital warts are the leading demand driver for HPV therapeutics. The high number of HPV strains that can cause genital warts, particularly when the disease is contracted through sexual contact, is responsible for the dominant share of the genital warts segment in the HPV therapeutics market.

By drug class, ganciclovir and valganciclovir dominate the demand from the CMV therapeutics market, while immunomodulators are the leading class of drugs prescribed for HPV.

Browse Full Research Report: http://bit.ly/1mQaMJj

Geographically, North America is the leading market for HPV and CMV therapeutics, with the regional HPV therapeutics market’s revenue expected to reach US$597.3 mn and the CMV therapeutics market’s revenue expected to reach US$202.2 mn by the end of 2016. Despite the substantial growth prospects of the Asia Pacific and Latin America markets for HPV and CMV therapeutics, the growing sexually active population and the ease of obtaining diagnostics and therapeutics in North America are likely to keep the latter dominant in the coming years.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Human Papillomavirus (HPV) Therapeutics Market to Reach US$2.34 bn by 2020, Driven by Rising Prevalence of HPV Infections here

News-ID: 355033 • Views:

More Releases from TMR Market Research

Metrology Services Market to Expand at 8.2% CAGR from 2012 to 2018, Burgeoning A …
Metrology services involve providing talented metrologists and reliable instrumentation and software to original equipment manufacturers. A good service provider not only brings equipment to its clients, but also extends repair and calibration services, equipment rental, automation and systems integration of measurement equipment, training, tool design, and more. According to the report, the high adoption rate of computer-aided design (CAD) and computer-aided manufacturing (CAM) and statutes for international quality standards are the
Global Failure Analysis Equipment Market to Expand at 8.8% CAGR, Rapid Progressi …
Failure analysis equipment is used to determine anomalies in the functioning of various processes and systems across manufacturing, biotechnology, service, and other industries. The equipment is used to detect the reasons of breakdowns or errors at a preliminary stage, which can help accrue considerable savings over time. The report states that rapid progression in nanotechnology, combined with the development of the medical sector in Asia Pacific, are the foremost reasons driving
Global Electric Motors Market Looks to Expansion of Automotive Sector, Set to Ri …
The competitive landscape of the global electric motors market includes players such as Baldor Electric Company Inc., Johnson Electric Holdings Ltd., Danaher Motion LLC, Ametek Inc., Siemens AG, Allied Motion Technologies Inc., Brook Crompton UK Ltd., and Franklin Electric Co. Inc. The market is highly fragmented with a number of international and domestic players trying to expand their businesses. This has restricted the established international brands from entering into new
User Preference for Improved Smart Devices Spurs Embedded Systems Manufacture Ra …
The leaders in the global embedded microcontroller systems market in 2014 were Renesas Electronics Corporation, Freescale Semiconductor, and Samsung Electronics Corporation. The three held a collective share of 54.8% of the market value in 2014.  As for embedded microprocessor systems, Intel Corporation, Qualcomm, Samsung Electronics, and Advanced Microdevices had collectively held a share 92% in terms of value in 2014.  Download PDF for Full Details with Technological breakthroughs is @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=995 According to a new publication

All 4 Releases


More Releases for HPV

Rising Prevalence Of HPV-Related Diseases Sparks Surge In Human Papillomavirus ( …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Human Papillomavirus (HPV) Vaccine Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, there's been speedy growth in the market size for the human papillomavirus (HPV) vaccine. Its worth is forecasted to increase from $5.8 billion in 2024 to $6.63 billion in 2025
Global Human Papillomavirus (HPV) Vaccine Market Report 2025: Insights, Drivers …
The Global Human Papillomavirus (HPV) Vaccine Market size reached US$ 3,043.19 Million in 2024 and is expected to reach US$ 12,361.15 Million by 2033, growing at a CAGR of 16.9% during the forecast period 2025-2033. The Human Papillomavirus (HPV) Vaccines Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data
Rising Prevalence Of HPV-Related Diseases Sparks Surge In Human Papillomavirus ( …
The Human Papillomavirus (HPV) Vaccine Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Human Papillomavirus (HPV) Vaccine Market Size During the Forecast Period? The market size for the human papillomavirus (HPV) vaccine has seen swift growth in the past few years. The
HPV Vaccines Market 2020-2026 - COVID19 Impact On HPV Vaccines Industry | Top Ke …
HPV Vaccines Market Size, Share & Industry Analysis, By Type (Bivalent and Polyvalent), By Disease Indication (HPV Associated Cancer and Genital Warts), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others) and Geography Forecast, 2019-2026. Get Sample Copy Of Report To Know The Impact of Covid19 on this Industry: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/human-papillomavirus-hpv-vaccines-market-101962 Top Key Players: GSK, Merck. An Overview of the Impact of COVID-19 on HPV Vaccines Market: The emergence of COVID-19 has brought
HPV Testing & PAP Test Market by Test Type (HPV Testing, Follow-up HPV Testing, …
Global HPV Testing & PAP Test Market was valued at USD XX billion in the year 2017. Global HPV Testing & PAP Test market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX billion by the year 2023. Get Free Access to Sample Report @ https://genesismarketinsights.com/Sample_Request/GENRE385 In the Global HPV Testing & PAP Test Market, by region, North America holds the highest market share
Cytology and HPV Testing Market: Disparate Levels of Awareness among Patients Re …
Over the years, the level of awareness among the global population regarding the various types of cancer has increased tremendously. The significance of early detection and diagnosis is not lost on them, resulting in the increased adoption of screening tests such as cytology and human papillomavirus (HPV) testing. The global market for cytology and HPV testing is presented with a host of sustained growth opportunities arising mainly from several emerging economies,